# LAS41005 in Hyperkeratotic Actinic Keratosis

> **NCT01358851** · PHASE2 · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 67 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **PROCEDURE:** Cryotherapy
- **DRUG:** LAS41005

## Key facts

- **NCT ID:** NCT01358851
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-03
- **Final completion:** 2012-08
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2015-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01358851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01358851, "LAS41005 in Hyperkeratotic Actinic Keratosis". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT01358851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*